The transcription factors GATA-3 and ThPOK are required for intrathymic differentiation of CD4 + T cells, but their precise functions in this process remain unclear. Here we show that, contrary to previous findings, Gata3 disruption blocked differentiation into the CD4 + T cell lineage before commitment to the CD4 + lineage and in some contexts permitted the 'redirection' of major histocompatibility complex class II-restricted thymocytes into the CD8 + lineage. GATA-3 promoted ThPOK expression and bound to a region of the locus encoding ThPOK established as being critical for ThPOK expression. Finally, ThPOK promoted differentiation into the CD4 + lineage in a way dependent on GATA-3 but inhibited differentiation into the CD8 + lineage independently of GATA-3. We propose that GATA-3 acts as a specification factor for the CD4 + lineage 'upstream' of the ThPOK-controlled CD4 + commitment checkpoint.
The transcription factors GATA-3 and ThPOK are required for intrathymic differentiation of CD4 + T cells, but their precise functions in this process remain unclear. Here we show that, contrary to previous findings, Gata3 disruption blocked differentiation into the CD4 + T cell lineage before commitment to the CD4 + lineage and in some contexts permitted the 'redirection' of major histocompatibility complex class II-restricted thymocytes into the CD8 + lineage. GATA-3 promoted ThPOK expression and bound to a region of the locus encoding ThPOK established as being critical for ThPOK expression. Finally, ThPOK promoted differentiation into the CD4 + lineage in a way dependent on GATA-3 but inhibited differentiation into the CD8 + lineage independently of GATA-3. We propose that GATA-3 acts as a specification factor for the CD4 + lineage 'upstream' of the ThPOK-controlled CD4 + commitment checkpoint.
Most T cells expressing antigen receptors (TCRs) specific for complexes of peptides and classical class Ia or class II MHC molecules belong to either of two lineages defined by the mutually exclusive expression of CD4 and CD8 surface glycoproteins. CD8 + T cells are typically MHC class I restricted and differentiate into cytotoxic effector cells after antigenic stimulation. In contrast, CD4 + T cells are typically MHC class II restricted and either positively (helper T cells) or negatively (regulatory T cells) influence immune responses. Cells of the CD4 + and CD8 + lineages differentiate from CD4 + CD8 + double-positive (DP) thymocyte precursors that, as a result of engagement of the TCR by intrathymic peptide-MHC complexes, undergo positive selection [1] [2] [3] .
Two transcription factors, ThPOK and GATA-3, are specifically required for the development of CD4 + T cells. ThPOK (also called cKrox or Zbtb7b) is expressed in CD4 + T cells but not in CD8 + T cells 4, 5 and belongs to a subset of zinc-finger transcription factors that share an additional amino-terminal region of homology known as the 'BTB-POZ domain' 6 . A spontaneous missense mutation of the gene encoding ThPOK (Zbtb7b; called 'ThPOK' here) in helperdeficient mice (ThPOK hd ) disrupts the development of CD4 + T cells and redirects MHC class II-restricted thymocytes into the CD8 + lineage 4 . Reciprocally, enforced expression of ThPOK in MHC class I-restricted thymocytes (where it is normally not expressed) results in redirection toward a CD4 + lineage fate 4, 5 . Thus, ThPOK controls a key lineage-commitment checkpoint. It is unclear whether the mutant ThPOK hd protein lacks any biological activity or whether it participates in early CD4 + differentiation or has aberrant activities that contribute to lineage redirection.
The zinc-finger transcription factor GATA-3 is expressed during and is required for many steps of T cell differentiation, both in developing thymocytes and effector T cells [7] [8] [9] . During positive selection, GATA-3 expression peaks during the transition from DP to CD4 + single positive (CD4 SP) and decreases during the transition from DP to CD8 SP 10, 11 . Targeted disruption of Gata3 in DP thymocytes has shown that GATA-3 is necessary for the development of CD4 + T cells but not CD8 + T cells [12] [13] [14] . However, unlike the ThPOK hd mutation, Gata3 disruption arrests the development of MHC class II-restricted thymocytes during the DP-to-CD4 SP transition but does not result in redirection to the CD8 + lineage 12 . Conversely, enhanced GATA-3 expression fails to redirect MHC class I-restricted thymocytes into the CD4 + lineage 11, 14 . Such observations have led to the conclusion that GATA-3 controls a post-commitment differentiation or survival step during the development of CD4 + T cells 9, 12 .
Thus, the model at present is that ThPOK directs CD4 + lineage 'choice' , whereas GATA-3 is needed for the terminal differentiation or survival of cells committed to the CD4 + lineage. Here we reassessed that model using mouse lines with loss-of-function Gata3 or ThPOK alleles. We found that, contrary to the model noted above, both transcription factors were required before CD4 + commitment.
GATA-3 was required for ThPOK expression, whereas ThPOK was not necessary for GATA-3 expression. Thus, the blockade caused by Gata3 disruption was 'upstream' of that caused by ThPOK disruption. Enforced ThPOK expression failed to restore the CD4 + differentiation of GATA-3-deficient thymocytes, which suggested that GATA-3 functions as a key CD4 + lineage-specification factor independently of its effects on ThPOK expression.
RESULTS
ThPOK disruption blocks commitment to the CD4 + lineage The ThPOK hd protein has an arginine-to-glycine substitution (R389G) at a position in its second zinc finger that is predicted to contact DNA and contribute to site-recognition specificity 4, 15 . This raises the possibility that the ThPOK hd allele is hypomorphic rather than null and that the phenotype of helper-deficient mice does not indicate the full extent of ThPOK functions. In addition, the mutant ThPOK hd protein could possibly function in earlier steps of T cell differentiation or might have an aberrant activity (such as DNA-binding specificity) that contributes to the redirection of MHC class II-restricted thymocytes into the CD8 + lineage. To evaluate those possibilities, we generated a null allele of ThPOK by disrupting the entire coding region of this gene (Supplementary Fig. 1 online) , thereby preventing the expression of ThPOK protein ( Supplementary Fig. 2 online) . ThPOK -/-mice obtained from heterozygous crosses developed until adulthood without detectable developmental abnormalities and were propagated through the mating of homozygous ThPOK -/-mice. Thus, despite the broad expression pattern of ThPOK 4,16 , its disruption did not affect organogenesis or early survival.
ThPOK -/-mice had impaired CD4 + T cell development similar to that of ThPOK hd mice 4 , with many fewer CD4 + T cells and correspondingly more CD8 + T cells in lymph nodes and spleen (Fig. 1a,b and data not shown). ThPOK -/-thymi had a large subset of CD4 + CD8 lo cells with high surface TCR expression characteristic of cells undergoing positive selection (Fig. 1a) ; however, these cells had high expression of CD24, a cell surface protein whose downregulation is contemporaneous with the final stages of thymocyte maturation. ThPOK -/-mice expressing the MHC class II-restricted AND TCR transgene showed diversion of MHC class II-restricted TCRtransgenic thymocytes and splenocytes from the CD4 + lineage to the CD8 + lineage (Fig. 1c,d ) similar to that of ThPOK hd mice. Thus, ThPOK is not required during T cell development before the CD4 + -CD8 + lineage-commitment checkpoint, and the redirection of MHC class II-restricted thymocytes to the CD8 + lineage in helper-deficient mice is not the result of any aberrant activity of the ThPOK hd mutant polypeptide.
GATA-3 controls a pre-CD4 + commitment checkpoint We next compared the CD4 + developmental blocks caused by disruption of ThPOK and Gata3. We used mice with conditional loxP-flanked Gata3 alleles 13 (Gata3 fl/fl ) and a transgene encoding Cd4-driven Cre recombinase (CD4-Cre) that on its own had no influence on thymocyte development (Gata3 DDP mice; Supplementary Fig. 3 online) . The CD4-Cre transgene inactivated the loxP-flanked Gata3 alleles after the early thymocyte developmental stages during which GATA-3 is required, which allowed the development of GATA-3-deficient DP thymocytes 12, 13 (Fig. 2a) . Gata3 DDP thymi contained cells with high expression of TCR and CD69, indicative of intrathymic TCR signal transduction (Fig. 2b) . However, the number of TCR hi CD4 SP thymocytes was much smaller in Gata3 DDP mice (0.2 Â 10 6 ± 0.04 Â 10 6 ) than in their wild-type counterparts (10.9 Â 10 6 ± 1.4 Â 10 6 ), and there was no defined TCR hi CD4 + CD8 lo subset, unlike in in ThPOK -/-thymi (Fig. 2a) . In contrast, the number of TCR hi CD8 SP thymocytes was not significantly lower in Gata3 DDP thymi (2.12 Â 10 6 ± 0.52 Â 10 6 ) than in wild-type thymi (2.62 Â 10 6 ± 0.43 Â 10 6 ). Unlike their ThPOK -/-counterparts, and in agreement with published findings [12] [13] [14] , GATA-3-deficient CD8 SP and CD4 + CD8 int thymocytes had slightly lower expression of TCR and CD69 (Fig. 2b) . Although Gata3 DDP mice had small peripheral CD4 + populations, these CD4 + T cells had an activated-memory phenotype 13 (data not shown), which suggested they arose by amplification of a small number of thymocytes that completed CD4 + differentiation as a result of delayed Cre-mediated deletion of the allele. Thus, Gata3 disruption in DP thymocytes had asymmetric consequences on the CD4 + and CD8 + lineages: development of the CD4 + lineage was arrested before or at the onset of CD8 downregulation, whereas development of the CD8 + lineage was only minimally affected. The absence of CD4 + CD8 lo cells in Gata3 DDP thymi, in contrast to their presence in ThPOK -/-thymi, raised the possibility that GATA-3 is required for the positive selection of MHC class II-restricted thymocytes. To explore that possibility, we crossed Gata3 DDP mice with recombination-activating gene 2-deficient (Rag2 -/-) mice expressing the I-E k -restricted 5CC7 TCR transgene 17 . On an H-2 k/k , GATA-3-sufficient background, this TCR promoted the generation of CD4 SP thymocytes with high expression of the V a 11-transgenic TCRa chain (Fig. 3a) . Although Gata3 inactivation resulted in considerable disruption of the development of CD4 + cells, V a 11 hi cells were present in Gata3 DDP 5CC7 TCR thymi, which indicated that the lack of GATA-3 did not prevent MHC class II-induced signaling. Unexpectedly, in Gata3 DDP thymi, a large subset of V a 11 hi cells had a CD4 -CD8 + surface phenotype and gave rise to peripheral CD8 + T cell populations (Fig. 3a,b and data not shown), which indicated redirection to the CD8 + lineage. Expression of the maturation markers CD5 and CD24 on these CD8 SP thymocytes was similar to that on GATA-3-sufficient 5CC7 thymocytes ( Supplementary Fig. 4 online), and they did not express CD122 (interleukin 2 receptor-b; data not shown).
The presence of 'CD8-redirected' MHC class II-restricted thymocytes in Gata3 DDP mice conflicted with published observations indicating that GATA-3-deficient thymocytes expressing the DO11.10 or AND MHC class II-restricted TCRs do not differentiate into CD8 + cells 9, 12 and suggested that the developmental block in Gata3 DDP thymi preceded commitment to the CD4 + lineage. It was possible that this discrepancy resulted from a higher avidity of the 5CC7 TCR than of the AND or DO11.10 TCR for intrathymic peptide-MHC ligands or from less dependence on CD4 for signaling. To 'bypass' such idiosyncrasies, we used bone marrow chimera experiments to assess the fate of MHC class II-restricted Gata3 DDP thymocytes expressing a diverse TCR repertoire. We adoptively transferred T cell-depleted GATA-3-sufficient (Gata3 fl/fl ) or GATA-3-deficient (Gata3 DDP ) bone marrow into lethally irradiated b 2 -microglobulin-deficient host mice, which lack surface expression of MHC class I. In these experiments, donorderived thymocytes developing in b 2 -microglobulin-deficient thymi encountered only peptide-MHC class II complexes and thus underwent only MHC class II-driven positive selection. As a result, GATA-3-sufficient cells were positively selected and gave rise to CD4 SP but not CD8 SP TCR hi thymocytes (Fig. 3c,d ). We obtained similar results whether we obtained donor bone marrow from Gata3 fl/fl mice or from Gata3 +/fl mice carrying the CD4-Cre transgene (Fig. 3c,d and Supplementary Fig. 5 online). GATA-3-deficient thymocytes also received MHC class II-driven TCR signals, as shown by the presence of donorderived CD69 + TCR int and TCR hi thymocytes in Gata3 DDP -donor chimeras (Fig. 3c) ; as expected, these cells failed to give rise to CD4 SP populations. However, Gata3 DDP -donor chimeras had small numbers of TCR hi CD8 SP thymocytes (Fig. 3c,d ), consistent with the results obtained with 5CC7 mice and indicative of CD8 + redirection. These CD8 SP thymocytes had expression of CD5 and CD24 similar to that of wild-type CD8 + cells ( Supplementary Fig. 6 online) and were selected by MHC class II molecules expressed on the thymic epithelium, as no T cells developed when recipients doubly deficient in MHC class I and class II were reconstituted with Gata3 DDP bone marrow (data not shown). These observations collectively demonstrate that GATA-3-deficient MHC class II-restricted thymocytes can undergo positive selection and indicate that such cells are arrested early in their differentiation, before commitment to the CD4 + lineage.
ThPOK expression requires GATA-3
To further examine the relationships between the GATA-3-and ThPOK-controlled lineage checkpoints, we assessed whether either factor affected expression of the other. We first evaluated if ThPOK was required for GATA-3 expression, which is normally upregulated as MHC class II-restricted thymocytes initiate positive selection 11 . We compared expression of GATA-3 mRNA and protein in the CD4 + CD8 int subset, in which GATA-3 expression is normally highest and which is present in both wild-type and ThPOK -/-mice. GATA-3 mRNA expression in these cells and upregulation of GATA-3 protein expression in CD4 + CD8 int cells relative to that of DP thymocytes were not affected by ThPOK disruption (Fig. 4a,b) . Thus, ThPOK is not required for the expression of GATA-3 in the thymus.
To evaluate the function of GATA-3 in ThPOK expression, we compared ThPOK protein expression in wild-type and Fig. 7 online) . We detected ThPOK protein in wild-type but not Gata3 DDP CD69 + cells (Fig. 4c) . 'Titration' of the wild-type input down to the detection limit showed that expression of ThPOK was at least 20-fold greater in wild-type than in Gata3 DDP thymocytes (Fig. 4d) . We concluded from these analyses that GATA-3 is required for the proper expression of ThPOK and thus that GATA-3 acts at least in part 'upstream' of ThPOK.
CD69 + thymocytes (Supplementary

GATA-3 dependency distinguishes two ThPOK functions
As GATA-3 was required for proper ThPOK expression but not for MHC class II-induced TCR signaling, we considered the possibility that intrathymically signaled Gata3 DDP thymocytes failed to undergo CD4 + differentiation because they failed to upregulate ThPOK. If that were the case, enforced expression of ThPOK should restore differentiation into the CD4 + lineage in Gata3 DDP mice. To evaluate that possibility, we complemented Gata3 DDP mice with a ThPOK transgene 5 expressed in DP thymocytes in amounts similar to endogenous ThPOK expression in CD4 + T cells ( Supplementary Fig. 8 online) .
As reported before 5 , expression of the ThPOK transgene in GATA-3-sufficient thymocytes resulted in complete loss of the CD8 SP thymocyte population but did not detectably affect CD4 SP thymocyte numbers (Fig. 5a,b) . Expression of the ThPOK transgene in Gata3 DDP mice did not restore TCR hi CD4 + CD8 -thymocyte numbers (Fig. 5a,b) , which suggested that ThPOK expression fails to promote the CD4 + differentiation of GATA-3-deficient thymocytes. Although the presence of substantial numbers of peripheral CD4 + T cells in ThPOK-transgenic Gata3 DDP mice challenged that conclusion (Supplementary Fig. 9 online) , these peripheral cells were of large size (with high forward scatter (FSC hi )) and expressed the memory marker CD44, as in Gata3 DDP mice 13 , which suggested that they emerged from the lymphopenia-driven expansion of an undetectable contingent of CD4 + -differentiating thymocytes that arose as a result of delayed inactivation of Gata3. Given that hypothesis, we predicted that no or few peripheral CD4 + cells would be present in the spleens of 1-week-old mice, in which mature T cell numbers more accurately reflect thymic output than they do in adult mice. That was indeed the case, as few cells, all of which had an FSC hi CD44 hi surface phenotype, were present in 1-week-old Gata3 DDP mice; in contrast, spleens from 1-week-old GATA-3-sufficient mice contained mainly FSC lo CD44 lo cells ( Fig. 5c and Supplementary Fig. 10 online). As with older Gata3 DDP mice, 1-week-old Gata3 DDP mice had no detectable CD4 SP thymic populations ( Supplementary  Fig. 10 ). We concluded from these findings that ThPOK fails to promote the CD4 + differentiation of thymocytes lacking GATA-3.
In contrast to its inability to restore differentiation into the CD4 + lineage, the ThPOK transgene in Gata3 DDP mice caused complete loss of CD8 SP thymocyte and peripheral CD8 + T cell populations (Fig. 5a) . This indicated that ThPOK-mediated inhibition of differentiation into the CD8 + lineage did not require GATA-3. Of note, the absence of both CD4 SP and CD8 SP populations in the thymus suggested that ThPOK failed to promote the CD4 + redirection of MHC class I-restricted cells in the absence of GATA-3.
GATA-3 binds the ThPOK locus
The finding GATA-3 acted 'upstream' of ThPOK and was needed for ThPOK to promote CD4 + differentiation raises the possibility that GATA-3 serves as a specification factor 18 for the CD4 + lineage by binding to and promoting expression of CD4 + lineage-specific genes. As a first assessment of that possibility, we examined whether GATA-3 molecules were recruited to the ThPOK locus in thymocytes. The ThPOK locus spans over 20 kilobases of mouse chromosome 3 ( Fig. 6a) and contains more than 15 motifs matching the GATA-3-binding consensus sequence (WGATAR, where 'W' represents A or T and 'R' represents A or G) 19, 20 . Consequently, we selected candidate regions on the basis of their location in functionally important gene regions and their conservation across species. This led us to focus on two motifs, which we called 'site A' and 'site B' (Fig. 6a and Supplementary Fig. 11 online) . Both motifs were present in a 3.7-kilobase region required for ThPOK expression, as shown by analysis of bacterial artificial chromosome (BAC) reporter transgenes (Fig. 6a,b) . More specifically, they were present in two areas of DNase I hypersensitivity 21 (L.W. et al., unpublished data), a hallmark of transcription factor-binding sites. Both motifs were conserved among many mammalian species ( Supplementary Fig. 11 ). Supplementary  Figure 11 shows their location and relationships with known ThPOK cis-regulatory elements; site B localized together with the regulatory element 'PRE' (proximal regulatory element) or enhancer 21, 22 , whereas site A was in a highly conserved downstream 150-base pair sequence. We did chromatin immunoprecipitation (ChIP) assays with crosslinked thymocyte chromatin to evaluate the recruitment of GATA-3 to sites A and B. These experiments showed consistent enrichment of both sites in GATA-3 immunoprecipitates relative to that of immunoprecipitates prepared with an isotype control antibody (Fig. 6c,d ). This enrichment was specific, as it was not present in chromatin prepared from GATA-3-deficient thymocytes and as there was no GATA-3 enrichment on an unrelated sequence present in the Cd8 gene enhancer E8(I) 23, 24 . In contrast, we found little or no specific recruitment of GATA-3 to a highly conserved GATA motif located 1.6 kilobases upstream of ThPOK exon 1 (data not shown). However, given the many GATA motifs in the ThPOK sequence and the limited sensitivity of the ChIP procedure, our search was necessarily not exhaustive and it is conceivable that GATA-3 is recruited to additional sites in the ThPOK locus. We conclude from these experiments that GATA-3 is recruited to at least two distinct sites in a region of the ThPOK locus required for ThPOK expression. Our findings, together with the requirement for GATA-3 for ThPOK expression, support the possibility that GATA-3 directly activates ThPOK transcription.
In summary, our study has shown that GATA-3 and ThPOK have essential and nonredundant functions during early CD4 + cell differentiation before lineage commitment. At this developmental stage, GATA-3 is required both for ThPOK expression and for additional, as-yet-unknown functions. In contrast, GATA-3 is not needed for ThPOK to inhibit CD8 + differentiation.
DISCUSSION
Our study has positioned the requirement for the zinc-finger transcription factors ThPOK and GATA-3 before the CD4 + lineagecommitment checkpoint. We have shown that GATA-3 was required early during CD4 + differentiation and, notably but not only, for the proper expression of ThPOK. In contrast, ThPOK disruption did not impair GATA-3 expression.
As shown before, the requirement for GATA-3 is selective; Gata3 disruption does not prevent differentiation into the CD8 + lineage and does not impair MHC class I-induced positive selection 12, 14 , consistent with the fact that this factor is downregulated in thymocytes of the CD8 + lineage 10, 11 . Here we found that MHC class II-restricted GATA-3-deficient thymocytes were able to, albeit inefficiently, develop into CD8 + cells. Thus, the requirement for GATA-3 identifies an early, precommitment branch point during which the gene-expression requirements of each lineage begin to diverge. Additional studies are needed to position this branch point relative to the steps controlled by the high-mobility group box protein Tox 25 and the transcription factor c-Myb 26, 27 . The redirection of Tox-deficient MHC class II-restricted thymocytes into the CD8 + lineage is less efficient that that of GATA-3-deficient thymocytes. Deficiency in c-Myb impairs CD4 + differentiation, but to a smaller extent than that caused by Gata3 disruption, and does not affect ThPOK expression 27 . Thus Tox, c-Myb and GATA-3 seem to have distinct functions during CD4 + differentiation.
Analyses of hematopoietic cell differentiation have led to the distinction between lineage specification, understood as the activation of lineage-specific expression, and lineage commitment, defined as the loss of alternative developmental fates 18 . One illustration of this dichotomy is found during B cell differentiation, in which the specification factors E2A and EBF promote expression of the B cellcommitment factor Pax5 (refs. 28, 29) . We propose that GATA-3 is required for CD4 + lineage specification and that it may serve this function through two, non-mutually-exclusive mechanisms. First, it is possible that GATA-3 directly acts as a specification factor to promote the expression of genes of the CD4 + lineage; our finding that GATA-3 was recruited to ThPOK cis-regulatory elements supports this possibility. As ThPOK failed to promote the CD4 + differentiation of GATA-3-deficient cells, future studies should focus on identifying additional CD4 + lineage-specific GATA-3 target genes. The second possibility is that GATA-3 acts indirectly to specify the CD4 + lineage by promoting the expression of one or more TCR signaling intermediate(s) required for CD4 + but not CD8 + differentiation. The present models of lineage 'choice' 2 propose that TCR signaling is of longer duration [30] [31] [32] or greater intensity 33, 34 in MHC class II-restricted thymocytes than in MHC class I-restricted thymocytes, which promotes a CD4 + rather than CD8 + fate and ensures the correspondence in mature T cells between MHC specificity and coreceptor expression. Thus, it is conceivable that GATA-3 indirectly contributes to CD4 + lineage specification by sustaining the expression of signaling intermediates that are required for CD4 + but not for CD8 + differentiation, even though their expression may not be CD4 + lineage specific. Although Gata3 disruption reportedly does not affect TCR signaling in DP thymocytes 12 , we noted that GATA-3-deficient thymocytes had lower surface expression of CD69 and TCR, both of which are upregulated by TCR signaling 12, 14 . In addition, GATA-3 negatively regulates the expression of CD5, a surface molecule that participates in a negative feedback control of TCR signal transduction 14, 35 .
Two distinct and potentially complementary mechanisms may contribute to the diminished 'redirection' of GATA-3-deficient thymocytes to the CD8 + lineage relative to that of ThPOK-deficient MHC class II-restricted thymocytes. First, if GATA-3 controls the expression of TCR signaling intermediates, its inactivation would decrease TCR signaling or make it more CD4 dependent and therefore would impair cell survival. In line with this possibility, we noted 'redirection' with the 5CC7 TCR, of high avidity for I-E k peptide-MHC complexes but not for the AND or DO11.10 TCRs, whose avidity for peptide-MHC is thought to be lower. In contrast, ThPOK is not involved in TCR signaling and therefore its absence would not affect the ability of CD4 + cells to be redirected.
Second, it is possible that additional factors contribute to prevent the CD8 + differentiation of MHC class II-signaled thymocytes before ThPOK expression. Indeed, although GATA-3 does not inhibit differentiation into the CD8 + lineage 11, 14, 36 (unlike ThPOK), MHC class IIsignaled thymocytes do not initiate the expression of genes of the CD8 + lineage. Thus, before ThPOK expression reaches a sufficient amount, other factors may transiently inhibit differentiation into the CD8 + lineage. In this context, although Gata3 disruption would prevent differentiation into the CD4 + lineage, it would not enable the expression of genes of the CD8 + lineage, which would explain the small size of the 'redirected' population in GATA-3-deficient mice. The transcription factor c-Myb is a possible candidate for transient repression of such genes, as a constitutively active form of c-Myb inhibits differentiation into the CD8 + lineage without 'redirecting' MHC class I-restricted thymocytes to the CD4 + lineage 27 . Expression of c-Myb is high in DP thymocytes, unlike that of GATA-3. It is downregulated during the DP-to-SP transition but is higher in thymocytes differentiating into the CD4 + lineage than in those differentiating into the CD8 + lineage. Additional analyses are needed to determine if disruption of Myb and Gata3 results in greater 'redirection' of MHC class II-restricted cells to the CD8 + lineage. Of note, the MHC class II-restricted thymocytes that were 'redirected' to the CD8 + lineage in the absence of GATA-3 were dependent on epithelial peptide-MHC class II complexes and did not express CD122, unlike CD8 + cells selected on peptide-MHC class I complexes expressed on hematopoietic thymic elements and having an 'innate' effector phenotype [37] [38] [39] .
During positive selection, ThPOK both inhibits CD8 + differentiation and promotes CD4 + differentiation 4, 5 ; thus, the issue arises of whether ThPOK contributes to both CD4 + specification and commitment or to CD4 + commitment only. In a simple model, specification factors turn on lineage-specific genes, whereas commitment factors turn off genes characteristic of alternative fates. As ThPOK belongs to a family of proteins that generally act as transcriptional repressors, it is conceivable that it indirectly promotes CD4 + differentiation by repressing genes of the CD8 + lineage induced by intrathymic signals 40 ; such targets could include Runx3 and as-yet-unidentified repressors of CD4 + differentiation. This simple model includes ThPOK as a key commitment factor that lacks specification activity and suggests that specification of the CD4 + lineage would rely on transcriptional activators, including GATA-3, that promote the expression of CD4 + lineage-specific genes. The absence (or insufficient expression) of ThPOK (such as in MHC class I-restricted or ThPOK-deficient thymocytes) would allow the upregulation of CD8 + -specification factors and of the CD8 + -commitment factor Runx3 (refs. 22,41,42) . Enforced expression of ThPOK in MHC class I-restricted thymocytes prevents CD8 + differentiation and promotes the CD4 + differentiation of those cells in which expression of CD4 + -specifying factors (including GATA-3) is sufficient to turn on the expression of genes of the CD4 + lineage.
Several lines of evidence support the model outlined above. Consistent with a commitment function, ThPOK inhibits the expression of Cd8 and of genes encoding cytotoxic molecules in post-thymic CD8 + cells 43 and antagonizes the repression of Cd4 expression by Runx molecules 44 . In contrast, ThPOK has a more modest effect on promoting the expression of genes of the CD4 + lineage in mature CD8 + cells 43 . Conversely, there is evidence that GATA-3 lacks commitment activity. Gain-of-function experiments have shown that enforced GATA-3 expression does not prevent CD8 + 'choice' 11, 14, 36 , whereas our finding that GATA-3 was not needed for ThPOK to inhibit CD8 + differentiation supports the possibility that the commitment function of ThPOK is GATA-3 independent. Variations on this model include the possibility that both GATA-3 and ThPOK participate in commitment (for example, because GATA-3 would be required for ThPOK to repress a subset of CD8 + -lineage genes) or that both GATA-3 and ThPOK participate in specification of the CD4 + lineage by directly promoting the expression of a common set of CD4 + lineage-specific genes or by triggering distinct target genes. Although there is no experimental evidence to support these possibilities at present, future analyses of ThPOK and GATA-3 gene targets are needed to exclude these possibilities.
The ThPOK distal regulatory element 21 (also called the 'silencer' 22 ) inhibits ThPOK expression in cells of the CD8 + lineage and in DP thymocytes (silencing function) and has also shown enhancer activity in transgenic reporter assays 21 . This element includes a motif (CGATTAG) that is distantly related to the GATA-3-binding sequence (WGATAR) and is notably atypical by the presence of a 'T' instead of an 'A' at position +4 of the GATA sequence 19, 20 . Whether this motif recruits GATA-3 or contributes to the putative enhancer function of the distal regulatory element has not been evaluated 21 . Experiments with conventional reporter transgenes have indicated that the CGATTAG motif is dispensable for the silencing function of the distal regulatory element 21 , in agreement with analyses by homologous recombination 22 .
The connections between transcription factors and TCR signal attributes that ensure the matching of lineage differentiation to MHC specificity and, notably, how ThPOK expression is restricted to MHC class II-signaled cells during positive selection 4, 5 are not understood. Whereas Runx proteins repress ThPOK expression 22 , neither Runx1 nor Runx3 is a known target of TCR signals. Furthermore, repression of ThPOK by Runx is cell context dependent, as Runx1 is expressed in and required for the survival of cells of the CD4 + lineage 45 and as ThPOK expression does not correlate with the recruitment of Runx complexes to the ThPOK silencer 22 . Finally, relieving Runx-mediated repression of ThPOK or deleting the ThPOK silencer that recruits Runx complexes results in only partial upregulation of ThPOK in preselection DP thymocytes 22 .
Such observations suggest that other transcription factors, recruited to additional ThPOK cis-regulatory elements, serve as 'relays' between TCR signaling and ThPOK upregulation. Our findings here, along with other published work, indicate that GATA-3 might act as such a 'link' between TCR signaling and ThPOK expression. GATA-3 has been proposed to serve as a sensor of TCR signaling during CD4 + -CD8 + differentiation 11 because it has higher expression in MHC class II-signaled cells than in MHC class I-signaled cells 32 and because thymocytes upregulate GATA-3 after TCR stimulation in vitro. If GATA-3 also promotes TCR signaling, it may furthermore serve as the 'engine' of a self-reinforcing loop that promotes ThPOK expression and CD4 + 'choice' . However, as enforced GATA-3 expression does not redirect MHC class I-restricted thymocytes into the CD4 + lineage 11 , it is likely that additional transcription factors recruited to positive regulatory elements in the ThPOK locus 21,22 also participate in TCR-induced upregulation of ThPOK.
METHODS
Targeted disruption of ThPOK and transgenic constructs. A ThPOK genetargeting vector was generated by recombination-mediated genetic engineering from the BAC clone RP23-64L17. The targeting vector included ThPOK sequences from position -7585 to position +5907 (where position '+1' is the 'A' residue in the ThPOK initiation codon), a neomycin-resistance cassette derived from pLTM330 inserted at position -212, and a loxP site derived from pLTM332 inserted at position +2263 (detailed cloning procedures, Supplementary Methods online). Recombinant embryonic stem cells were selected after transfection with the targeting vector with G418 and guancyclovir as described 46 and were screened by Southern blot analysis (strategy, Supplementary Fig. 1 ). Of 31 recombinant clones obtained, 2 were used for blastocyst injection, of which 1 gave rise to the line used here. Deletion of the loxP-flanked segments was achieved by crossing of mice heterozygous for the recombinant allele with mice expressing Cre under the control of a b-actin promoter. The genotype of recombinant mice was confirmed by Southern blot analysis for the first two generations and was subsequently confirmed by PCR analysis of DNA obtained from tail tissue. Green fluorescent protein (GFP) BAC reporter constructs were generated as described in the Supplementary Methods (primers, Supplementary Table 1 online).
Mice. Mice carrying a loxP-flanked Gata3 allele and a CD4-Cre transgene 13, 47 , a b-actin-Cre transgene 46 or a ThPOK transgene 5 (C8 line) have been described. AND TCR transgenic mice 48 and Rag2-deficient 5CC7 TCR transgenic mice 17 were from the Jackson Laboratories and Taconic, respectively. Mice deficient in b 2 -microglobulin were from Taconic, and MHC class II-deficient mice were from the Jackson Laboratories. Mice with the various genotypes studied were generated by the appropriate intercrosses or backcrosses. All mice were housed in specific pathogen-free facilities. Mice were genotyped by PCR analysis of DNA obtained from tail tissue or were phenotyped by staining of peripheral blood cells and were analyzed between 4 and 12 weeks of age except where indicated otherwise. All transgenic mice were heterozygous for the transgenic allele. For bone marrow-chimera experiments, bone marrow suspensions were depleted of mature T cells with antibody to Thy-1.2 (anti-Thy-1.2; J1J) and anti-CD5 (C3PO; both prepared in the laboratory of B.J.F.) plus low-toxicity rabbit complement (Cedarlane). Irradiated MHC-deficient recipients (800 rads; cesium source) were reconstituted with T cell-depleted bone marrow preparations and were maintained on water containing antibiotics until they were analyzed at 4-6 weeks after reconstitution. Animal procedures were approved by the Animal Care and Use Committee of the National Cancer Institute or the National Institute of Allergy and Infectious Diseases.
Gene and protein expression. Cells were prepared from thymus, spleen or lymph nodes and were counted and analyzed by flow cytometry according to published procedures 49 with an LSRII (BD Biosciences) or a modified (Cytek) FACSCalibur (BD Biosciences). Cells were sorted as described 32 with a FACSVantage or FACSAria (BD Biosciences). CD69 + cells were purified with anti-fluorescein isothiocyanate beads (Miltenyi) after being stained with fluorescein isothiocyanate-conjugated anti-CD69. Gene expression was analyzed by RT-PCR as described 43 . RNA was extracted with RNAqueous (Ambion) and was reverse-transcribed by oligo(dT) priming (SuperScript III; Invitrogen). Taqman reagents, probes (Gata3 probe reference Mm00484683_m1) and an ABI PRISM 7500HT were used for PCR (all from Applied Biosystems). Gene-expression values were normalized to those of Actb (encoding b-actin) in the same sample. For protein analysis, cells were lysed in buffer containing 1% (vol/vol) Triton X-100; total cell extracts or anti-ThPOK immunoprecipitates were separated by 10% SDS-PAGE in reducing conditions, were transferred to polyvinylidene difluoride membranes (Immobilon-P; Millipore) and were analyzed by immunoblot and chemiluminescence as described 5 .
Antibodies. A rabbit antibody directed against a glutathione S-transferase fusion protein including amino acids 167-335 of mouse ThPOK was derived by conventional procedures; its specificity was confirmed by transient transfection assays in human embryonic kidney 293T cells (Supplementary Fig. 2a) . Mouse anti-GATA-3 (HG3-31) and control immunoglobulin G1 (3E8) were from Santa Cruz Biotechnology; anti-b-actin (AC-15) was from Sigma; and staining antibodies are in Supplementary Table 2 online.
ChIP. AND TCR thymocytes or GATA-3-deficient thymocytes were analyzed with a Chromatin Immunoprecipitation (ChIP) Assay kit according to the manufacturer's instructions (Upstate Biotechnology) with minor modifications (Supplementary Methods) and the appropriate primers (Supplementary Table 3 online). Immunoprecipitated DNA was quantified with SYBR Green quantitative PCR; results are presented as 'fold enrichment' relative to the expression of Gapdh (encoding glyceraldehyde phosphate dehydrogenase), evaluated for each site x as follows:
where C x Gata3 and C x IgG1 are the number of cycles for detection of target x in anti-GATA-3 or control immunoprecipitates, respectively.
Statistical analysis. The two-tailed rank sum Wilcoxon test was used for the statistical analyses in Figure 5b .
Note: Supplementary information is available on the Nature Immunology website. 
